<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(1)</volume><submitter>Vikramdeo K</submitter><journal>Journal of ovarian research</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12337402</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MYB/AKT3 axis is a key driver of ovarian cancer growth, aggressiveness, and chemoresistance</pubmed_title><pmcid>PMC12337402</pmcid><pubmed_authors>Srivastava S</pubmed_authors><pubmed_authors>Vikramdeo K</pubmed_authors><pubmed_authors>Sharma A</pubmed_authors><pubmed_authors>Miree O</pubmed_authors><pubmed_authors>Anand S</pubmed_authors><pubmed_authors>Rocconi R</pubmed_authors><pubmed_authors>Singh A</pubmed_authors><pubmed_authors>Singh S</pubmed_authors></additional><is_claimable>false</is_claimable><name>MYB/AKT3 axis is a key driver of ovarian cancer growth, aggressiveness, and chemoresistance</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-04-18T13:04:05.542Z</modification><creation>2026-04-07T14:35:50.71Z</creation></dates><accession>S-EPMC12337402</accession><cross_references/></HashMap>